ArticleFish physiology and biochemistry2026
Lecithin supplementation to HFD improves largemouth bass liver health: Implications for regulating lipid homeostasis, antioxidant responses and endoplasmic reticulum stress.
Article in Fish physiology and biochemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Dietary lipids serve as economical energy sources in aquaculture feeds. Elevating lipid content promotes protein conservation and mitigates nitrogen waste. Fish health, however, can be severely impacted by fatty liver resulting from prolonged high-fat diet (HFD) feeding. Adding lecithin to the feed might be a potential improvement solution. This study investigated how dietary lipid and phospholipid levels affect hepatic lipid homeostasis, endoplasmic reticulum (ER) stress, and redox balance in largemouth bass. Five diets were formulated: a control (10.67% lipid, no added lecithin), a normal-lipid diet with 1.0 g/kg lecithin, the HFD (18.65% lipid, no added lecithin), and the HFD supplemented with either 1.0 or 2.0 g/kg lecithin (HFD + lecithin 1, HFD + lecithin 2). Lecithin supplementation reversed HFD-induced intrahepatic fat deposition while mitigating the decline in hepatic polyunsaturated fatty acids content. Lecithin supplementation mitigated HFD-stimulated increases in hepatic triglyceride, total cholesterol, key lipogenic enzyme activities, and mRNA levels of lipogenic genes/transcription factors. Furthermore, lecithin lessened the impact of HFD on hepatic very low density lipoprotein (VLDL), preventing both a lessened VLDL content and diminished VLDL secretion. Regarding ER stress and antioxidant responses: dietary lecithin addition alleviated HFD-induced increment of mRNA levels of ER stress markers and MDA content, and mitigated HFD-induced reduction of hepatic total superoxide dismutase, catalase, and total antioxidant capacity. This demonstrates lecithin's protective role against HFD-induced hepatic injury by restoring lipid homeostasis, alleviating ER stress, and strengthening antioxidant capacity.
Indexed as
Identifiers
41661360What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.